Harbor Capital Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-133
Closed -$26K – 1481
2025
Q4
$26K Buy
133
+6
+5% +$1.21K ﹤0.01% 796
2025
Q3
$26K Buy
127
+49
+63% +$8.69K ﹤0.01% 772
2025
Q2
$14K Sell
78
-40
-34% -$6.02K ﹤0.01% 880
2025
Q1
$16K Sell
118
-15
-11% -$1.98K ﹤0.01% 854
2024
Q4
$17K Buy
133
+5
+4% +$743 ﹤0.01% 845
2024
Q3
$21K Buy
+128
New +$19.4K ﹤0.01% 817
2023
Q3
– Sell
-181
Closed -$14.7K – 626
2023
Q2
$14.7K Buy
+181
New +$12.9K ﹤0.01% 622

Other funds holding THC

Harbor Capital Advisors's THC Position: Q1 2026 in Review

Harbor Capital Advisors sold out of Tenet Healthcare (THC) in Q1 2026, closing a stake of 133 shares — an estimated $26K sold.

Harbor Capital Advisors first reported a position in THC in Q2 2023 and held it in 7 quarters. The position peaked at $26K in Q4 2025. 695 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Harbor Capital Advisors reported no remaining Tenet Healthcare position as of Q1 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 133 Tenet Healthcare shares in Q1 2026, an estimated $26K.
  • Harbor Capital Advisors first reported a position in Tenet Healthcare in Q2 2023 and held it in 7 quarters.
  • Harbor Capital Advisors's Tenet Healthcare position peaked at $26K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.